Indivior PLC Sustainability Reports
Indivior develops, manufactures, and distributes buprenorphine-based prescription medicines primarily focused on treating opioid use disorder and serious mental illnesses.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 213800V3NCQTY7IED471
FIGI: BBG003T4KGV1
16 reports from 2014 to 2025
